Zobrazeno 1 - 10
of 36
pro vyhledávání: '"James H, Sondheimer"'
Autor:
Alexander S. Leidner, Xuan Cai, Leila R. Zelnick, Jungwha Lee, Nisha Bansal, Andreas Pasch, Mayank Kansal, Jing Chen, Amanda Hyre Anderson, James H. Sondheimer, James P. Lash, Raymond R. Townsend, Alan S. Go, Harold I. Feldman, Sanjiv J. Shah, Myles Wolf, Tamara Isakova, Rupal C. Mehta, Lawrence J. Appel, MD, MPH, Jing Chen, MD, MMSc, MSc, Debbie L. Cohen, MD, Harold I. Feldman, MD, MSCE, Alan S. Go, MD, James P. Lash, MD, Robert G. Nelson, MD, PhD, MS, Mahboob Rahman, MD, Panduranga S. Rao, MD, Vallabh O. Shah, PhD, MS, Mark L. Unruh, MD, MS
Publikováno v:
Kidney Medicine, Vol 5, Iss 11, Pp 100723- (2023)
Rationale & Objective: Heart failure (HF) is an important cause of morbidity and mortality among individuals with chronic kidney disease (CKD). A large body of evidence from preclinical and clinical studies implicates excess levels of fibroblast grow
Externí odkaz:
https://doaj.org/article/8c1713b6e8d342b98764f7e852bba1ef
Autor:
Paula F. Orlandi, Naohiko Fujii, Jason Roy, Hsiang-Yu Chen, L. Lee Hamm, James H. Sondheimer, Jiang He, Michael J. Fischer, Hernan Rincon-Choles, Geetha Krishnan, Raymond Townsend, Tariq Shafi, Chi-yuan Hsu, John W. Kusek, John T. Daugirdas, Harold I. Feldman, the CRIC Study Investigators
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-11 (2018)
Abstract Background Hematuria is associated with chronic kidney disease (CKD), but has rarely been examined as a risk factor for CKD progression. We explored whether individuals with hematuria had worse outcomes compared to those without hematuria in
Externí odkaz:
https://doaj.org/article/d102065aee5146cc9dd055904a4e417e
Autor:
Lawrence J. Appel, Pandu Rao, James P. Lash, Debbie L. Cohen, Sarah J. Schrauben, Clarissa J. Diamantidis, Sylvia E. Rosas, Chi-yuan Hsu, Aditya Surapaneni, Julia J. Scialla, Cric Study Investigators, James H. Sondheimer, Sankar D. Navaneethan, Jesse Y. Hsu, Jeffrey C. Fink, Morgan E. Grams, Dawei Xie, Alfred K. Cheung, Bernard G. Jaar, Harold I. Feldman
Publikováno v:
Nephrology Dialysis Transplantation. 36:1685-1693
Background Patients with chronic kidney disease (CKD) face risks of not only end-stage kidney disease (ESKD), cardiovascular disease (CVD) and death, but also decline in kidney function, quality of life (QOL) and mental and physical well-being. This
Autor:
Jing Chen, Matthew R. Weir, Dominic S. Raj, Anand Srivastava, Sophia Zhao, Sagar U. Nigwekar, Anne Frydrych, Tariq Shafi, Andrew S. Allegretti, Rajat Deo, James H. Sondheimer, James P. Lash, Ravi Thadhani, Anders H. Berg, Subbian Ananth Karumanchi, Cric Study Investigators, Sahir Kalim
Publikováno v:
Nephrology Dialysis Transplantation. 37:139-147
Background Protein carbamylation is a post-translational protein modification caused, in part, by exposure to urea’s dissociation product cyanate. Carbamylation is linked to cardiovascular outcomes and mortality in dialysis-dependent end-stage kidn
Autor:
Jiang He, Harold I. Feldman, Alan S. Go, Panduranga S. Rao, Nisha Bansal, Charles E. McCulloch, Wei Yang, Ed Horwitz, Tariq Shafi, Ana C. Ricardo, James H. Sondheimer, Raymond R. Townsend, Chi-yuan Hsu, Lawrence J. Appel, James P. Lash, Mahboob Rahman, Elaine Ku, John W. Kusek, Sushrut S. Waikar
Publikováno v:
Am J Kidney Dis
Rationale & Objectives Few studies have investigated racial disparities in survival among dialysis patients in a manner that considers risk factors and mortality during the phase of kidney disease before maintenance dialysis. Our objective was to exp
Autor:
Rasheeda K. Hall, Jacob B. Blumenthal, Rebecca M. Doerfler, Jing Chen, Clarissa J. Diamantidis, Bernard G. Jaar, John W. Kusek, Krishna Kallem, Mary B. Leonard, Sankar D. Navaneethan, Daohang Sha, James H. Sondheimer, Lee-Ann Wagner, Wei Yang, Min Zhan, Jeffrey C. Fink, Lawrence J. Appel, Harold I. Feldman, Alan S. Go, Mahboob Rahman, Panduranga S. Rao, Vallabh O. Shah, Raymond R. Townsend, Mark L. Unruh
Publikováno v:
Am J Kidney Dis
Rationale & Objective Adults with chronic kidney disease (CKD) may be at increased risk of adverse effects from use of potentially inappropriate medications (PIMs). Our objective was to assess whether PIM exposure has an independent association with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b2efc9a3a1e56f849beabc81017b877
https://europepmc.org/articles/PMC8608689/
https://europepmc.org/articles/PMC8608689/
Autor:
Nashat Imran, Zeenat Bhat, James H. Sondheimer, Yahya Osman-Malik, Mohamed Omer, Nanette Fonte
Publikováno v:
International Journal of Nephrology, Vol 2021 (2021)
International Journal of Nephrology
International Journal of Nephrology
Background and Objectives. Calcific uremic arteriolopathy (CUA) is a rare complication seen, especially in patients undergoing renal replacement therapy (RRT) with high morbidity and mortality. CUA treatment remains challenging. The study evaluated C
Autor:
Alan S. Go, Susana Arrigain, Tariq Shafi, Charles A. McKenzie, Bryan Addeman, Vallabh O. Shah, James H. Sondheimer, Ed Horwitz, Jeffrey C. Fink, Mark Unruh, Erika Schneider, Jiang He, Erick M. Remer, John P. Kirwan, Panduranga S. Rao, Lawrence J. Appel, Harold I. Feldman, Robert G. Nelson, Mahboob Rahman, Jonathan J. Taliercio, Jesse D. Schold, Sankar D. Navaneethan, James P. Lash, Raymond R. Townsend
Publikováno v:
Paediatrics Publications
Am J Kidney Dis
Am J Kidney Dis
Rationale & Objectives Adiposity and physical fitness levels are major drivers of cardiometabolic risk, but these relationships have not been well-characterized in chronic kidney disease (CKD). We examined the associations of visceral adipose tissue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d248f68b896a77258dee3b4a68d5fced
https://ir.lib.uwo.ca/paedpub/1528
https://ir.lib.uwo.ca/paedpub/1528
Autor:
Myles Wolf, Xiaoming Zhang, Santosh L. Saraf, James H. Sondheimer, L. Lee Hamm, James P. Lash, Matthew R. Weir, Teresa K. Chen, Ana C. Ricardo, Jing Chen, Rupal Mehta, Michael J. Fischer, Jesse Y. Hsu
Publikováno v:
Kidney360
BACKGROUND: Chronic kidney disease (CKD) progression can be a cause and potentially a consequence of anemia. Previous studies suggesting that anemia is associated with CKD progression have not utilized methodologic approaches to address time-dependen
Autor:
James H. Sondheimer, Xue Wang, Raymond R. Townsend, Cric Study Investigators, Wei Yang, L. Lee Hamm, Rajat Deo, Jordana B. Cohen, Krishna Kallem, Paula Orlandi, Jiang He, Sarah J. Schrauben, Dawei Xie, Ana C. Ricardo, Harold I. Feldman, Amanda H. Anderson, Dominic S. Raj, Afshin Parsa
Publikováno v:
Journal of the American Society of Nephrology : JASN. 31(12)
Background Slopes of eGFR have been associated with increased risks of death and cardiovascular events in a U-shaped fashion. Poor outcomes in individuals with rising eGFR are potentially attributable to sarcopenia, hemodilution, and other indicators